Masayuki Saruta

5.1k total citations
154 papers, 2.3k citations indexed

About

Masayuki Saruta is a scholar working on Surgery, Epidemiology and Genetics. According to data from OpenAlex, Masayuki Saruta has authored 154 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Surgery, 49 papers in Epidemiology and 33 papers in Genetics. Recurrent topics in Masayuki Saruta's work include Inflammatory Bowel Disease (31 papers), Liver Disease Diagnosis and Treatment (21 papers) and Microscopic Colitis (17 papers). Masayuki Saruta is often cited by papers focused on Inflammatory Bowel Disease (31 papers), Liver Disease Diagnosis and Treatment (21 papers) and Microscopic Colitis (17 papers). Masayuki Saruta collaborates with scholars based in Japan, United States and United Kingdom. Masayuki Saruta's co-authors include Konstantinos A. Papadakis, Qi Yu, Phillip Fleshner, Alison H. Banham, Yuichi Torisu, Chisato Saeki, Tsunekazu Oikawa, Hironobu Sasano, Kazuhiro Takahashi and Armine Avanesyan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Masayuki Saruta

139 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masayuki Saruta Japan	28	515	509	491	485	421	154	2.3k
Pietro Di Lucia Italy	18	1.2k 2.4×	481 0.9×	139 0.3×	175 0.4×	338 0.8×	25	2.7k
Shue‐Fen Luo Taiwan	37	906 1.8×	603 1.2×	476 1.0×	243 0.5×	971 2.3×	101	3.7k
Hiromi Iwagaki Japan	28	784 1.5×	321 0.6×	619 1.3×	91 0.2×	726 1.7×	202	2.6k
Matilde Bustos Spain	29	474 0.9×	420 0.8×	492 1.0×	305 0.6×	579 1.4×	59	2.2k
J S Kenney United States	11	983 1.9×	697 1.4×	268 0.5×	264 0.5×	550 1.3×	11	2.4k
Peter Rubin United States	24	826 1.6×	621 1.2×	543 1.1×	867 1.8×	241 0.6×	65	2.6k
Yan Liang China	28	704 1.4×	615 1.2×	462 0.9×	230 0.5×	732 1.7×	123	3.2k
Michael Yaron Israel	28	396 0.8×	230 0.5×	256 0.5×	248 0.5×	390 0.9×	61	2.3k
John Highton New Zealand	29	570 1.1×	317 0.6×	247 0.5×	288 0.6×	473 1.1×	106	2.4k
Victorine Douin‐Echinard France	24	901 1.7×	197 0.4×	181 0.4×	451 0.9×	573 1.4×	42	2.2k

Countries citing papers authored by Masayuki Saruta

Since Specialization

Citations

This map shows the geographic impact of Masayuki Saruta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayuki Saruta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayuki Saruta more than expected).

Fields of papers citing papers by Masayuki Saruta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayuki Saruta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayuki Saruta. The network helps show where Masayuki Saruta may publish in the future.

Co-authorship network of co-authors of Masayuki Saruta

This figure shows the co-authorship network connecting the top 25 collaborators of Masayuki Saruta. A scholar is included among the top collaborators of Masayuki Saruta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayuki Saruta. Masayuki Saruta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Niwa, Takashi, Chisato Saeki, Mitsuru Saito, et al.. (2025). Impact of frailty and prevalent fractures on the long-term prognosis of patients with cirrhosis: a retrospective study. Scientific Reports. 15(1). 186–186. 2 indexed citations

Matsuoka, Katsuyoshi, Fumihito Hirai, Kenji Watanabe, et al.. (2025). Optimising carotegrast methyl use in ulcerative colitis: patient profiling, predictive biomarkers, and timing of efficacy evaluation (ASPECT study). Journal of Gastroenterology. 60(12). 1523–1534.

Omori, Teppei, et al.. (2025). P0269 Examination of the safety and effectiveness of budesonide rectal foam for patients with Ulcerative Colitis: Final report of post-marketing surveillance in Japan. Journal of Crohn s and Colitis. 19(Supplement_1). i704–i704.

Takagi, Jun, Seiji Arihiro, Tomohiro Kato, et al.. (2024). Evaluation of a Chemiluminescent Enzyme Immunoassay for the Detection of Prostaglandin E‐Major Urinary Metabolite (PGE‐MUM). Journal of Clinical Laboratory Analysis. 38(19-20). e25102–e25102.

Koido, Shigeo, Junichi Taguchi, Shin Kan, et al.. (2024). Dendritic cells pulsed with multifunctional Wilms’ tumor 1 (WT1) peptides combined with multiagent chemotherapy modulate the tumor microenvironment and enable conversion surgery in pancreatic cancer. Journal for ImmunoTherapy of Cancer. 12(10). e009765–e009765. 13 indexed citations

Saruta, Masayuki, et al.. (2024). Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib. Journal of Medical Economics. 27(1). 566–574. 4 indexed citations

Tamura, Yuki, Chisato Saeki, Tomoya Kanai, et al.. (2024). Comparison of the ability between dual‐energy X‐ray absorptiometry and bioelectrical impedance analysis for diagnosing low skeletal muscle mass and sarcopenia in patients with chronic liver disease. Journal of Gastroenterology and Hepatology. 40(1). 274–281. 2 indexed citations

Peyrin‐Biroulet, Laurent, Peter Bossuyt, Dominik Bettenworth, et al.. (2024). Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis. Digestive Diseases and Sciences. 69(5). 1808–1825. 7 indexed citations

Arihiro, Seiji, Yoji Ogasawara, Masayuki Kato, et al.. (2023). A rare case of Epstein–Barr virus-positive diffuse large B-cell lymphoma, not otherwise specified, in a patient with ulcerative colitis. Clinical Journal of Gastroenterology. 16(4). 543–549.

10.

Saeki, Chisato, Tomoya Kanai, Kaoru Ueda, et al.. (2023). Insulin-like growth factor 1 predicts decompensation and long-term prognosis in patients with compensated cirrhosis. Frontiers in Medicine. 10. 1233928–1233928. 4 indexed citations

11.

Sakurai, Toshiyuki, Tomoko Saito, Takuji Yamasaki, et al.. (2022). Prostaglandin E‐major urinary metabolite diagnoses mucosal healing in patients with ulcerative colitis in remission phase. Journal of Gastroenterology and Hepatology. 37(5). 847–854. 15 indexed citations

12.

Ando, Yukio, Daisuke Endo, Hiroshi Yokoyama, et al.. (2021). Contribution of Capsule Endoscopy Early in a Bleeding Episode to Treatment of Small Bowel Angioectasia: A Case Report. Medicina. 57(4). 321–321. 1 indexed citations

13.

Yamada, Kohji, Tsunekazu Oikawa, Saishu Yoshida, et al.. (2020). Unconventional Secretion of PKCδ Exerts Tumorigenic Function via Stimulation of ERK1/2 Signaling in Liver Cancer. Cancer Research. 81(2). 414–425. 18 indexed citations

14.

Sakurai, Toshiyuki & Masayuki Saruta. (2020). Immune dysregulation, Polyendocrinopathy, Enteropathy, and X-linked syndrome. 246–250. 1 indexed citations

15.

Nishimura, Takashi, Makoto Mitsunaga, Kimihiro Ito, Hisataka Kobayashi, & Masayuki Saruta. (2019). Cancer neovasculature-targeted near-infrared photoimmunotherapy (NIR-PIT) for gastric cancer: different mechanisms of phototoxicity compared to cell membrane-targeted NIR-PIT. Gastric Cancer. 23(1). 82–94. 26 indexed citations

16.

Yokoyama, Hiroshi, Takahiro Masaki, Ikuyo Inoue, et al.. (2019). Histological and biochemical evaluation of transforming growth factor-β activation and its clinical significance in patients with chronic liver disease. Heliyon. 5(2). e01231–e01231. 11 indexed citations

17.

Ito, Kimihiro, Makoto Mitsunaga, Takashi Nishimura, et al.. (2017). Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody–Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer. Bioconjugate Chemistry. 28(5). 1458–1469. 30 indexed citations

18.

Ito, Kimihiro, Makoto Mitsunaga, Seiji Arihiro, et al.. (2016). Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms. BMC Cancer. 16(1). 37–37. 39 indexed citations

19.

Arihiro, Seiji, Eri Hayashi, Shunsuke Kamba, et al.. (2016). A Giant Gastrointestinal Stromal Tumor of the Stomach with Extramural Growth. Case Reports in Gastroenterology. 10(2). 344–351. 1 indexed citations

20.

Saruta, Masayuki, Qi Yu, Armine Avanesyan, et al.. (2007). Phenotype and Effector Function of CC Chemokine Receptor 9-Expressing Lymphocytes in Small Intestinal Crohn’s Disease. The Journal of Immunology. 178(5). 3293–3300. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact